How Do Restrictions on Advertising Affect Consumer Search?

References

• Bate R, Jin GZ, Mathur A (2013) In whom we trust: The role of certification agencies in online drug markets. B.E. J. Econom. Anal. Policy 14(1):111–150.Crossref, Google Scholar
• Bechtold S, Tucker C (2014) Trademarks, triggers, and online search. J. Empirical Legal Stud. 11(4):718–750.Crossref, Google Scholar
• Blake T, Nosko C, Tadelis S (2015) Consumer heterogeneity and paid search effectiveness: A large scale field experiment. Econometrica 83:155–174.Crossref, Google Scholar
• Boscaljon B (2005) Regulatory changes in the pharmaceutical industry. Internat. J. Bus. 10:151–164.Google Scholar
• Calfee JA, Winston C, Stempski R (2002) Direct to consumer advertising and the demand for cholesterol reducing drugs. J. Law Econom. 45(s2):673–690.Crossref, Google Scholar
• Campbell SM (2009) Promotional Spending for Prescription Drugs (Congressional Budget Office, Washington, DC).Google Scholar
• Chiou L, Tucker C (2018) Fake news and advertising on social media: A study of the anti-vaccination movement. NBER Working Paper No. 25223, National Bureau of Economic Research, Cambridge, MA.Google Scholar
• David G, Markowitz S, Richards-Shubik S (2010) The effects of pharmaceutical marketing and promotion on adverse drug events and regulation. Amer. Econom. J. Econom. Policy 2:1–25.Crossref, Google Scholar
• De Los Santos B, Hortacsu A, Wildenbeest MR (2012) Testing models of consumer search using data on web browsing and purchasing behavior. Amer. Econom. Rev. 102(6):2955–2980.Crossref, Google Scholar
• Donohue JM (2006) Direct-to-consumer advertising of prescription drugs: Does it add to the overuse and inappropriate use of prescription drugs or alleviate underuse? Internat. J. Pharmaceutical Medicine 20(8):17–24.Crossref, Google Scholar
• Donohue JM, Cevasco M, Rosenthal MB (2007) A decade of direct-to-consumer advertising of prescription drugs. New England J. Medicine 357(7):673–681.Crossref, Google Scholar
• Gentzkow M, Shapiro JM (2011) Ideological segregation online and offline. Quart. J. Econom. 126:1799–1839.Crossref, Google Scholar
• Goldfarb A, Tucker C (2011a) Advertising bans and the substitutability of online and offline advertising. J. Marketing Res. 48(2):207–227.Crossref, Google Scholar
• Goldfarb A, Tucker C (2011b) Search engine advertising: Channel substitution when pricing ads to context. Management Sci. 57(3):458–470.Link, Google Scholar
• Heine C (2010). Pharma on Facebook: FDA Cites Novartis Violations. ClickZ, August 9.Google Scholar
• Iizuka T, Jin GZ (2005) The effect of prescription drug advertising on doctor visits. J. Econom. Management Strategy 14(3):701–727.Crossref, Google Scholar
• Laugesen M, Meads C (1991) Tobacco advertising restrictions, price, income and tobacco consumption in OECD countries, 1960-1986. British J. Addiction 86:1343–1354.Crossref, Google Scholar
• Lewis RA, Rao JM (2016) The unfavorable economics of measuring the returns to advertising. Quart. J. Econom. 130(4):1941–1974.Google Scholar
• Lewis RA, Reiley DH (2014) Online ads and offline sales: measuring the effect of retail advertising via a controlled experiment on Yahoo! Quant. Marketing Econom. 12(3):235–266.Crossref, Google Scholar
• Limbu YB, McKinley C, Temperini V (2019) A longitudinal examination of FDA warning and untitled letters issued to pharmaceutical companies for violations in drug promotion standards. J. Consumer Affairs 53(1):3–23.Crossref, Google Scholar
• McNab C (2009) What social media offers to health professionals and citizens. Bull. World Health Organization 87(8):566.Google Scholar
• Montgomery AL, Li S, Srinivasan K, Liechty JC (2004) Modeling online browsing and path analysis using clickstream data. Marketing Sci. 23(4):579–595.Link, Google Scholar
• Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C (2013) A new dimension of healthcare: Systematic review of the uses, benefits, and limitations of social media for health communication. J. Medical Internet Res. 15(4):e85.Crossref, Google Scholar
• Narayanan S, Desiraju R, Chintagunta PK (2004) ROI implications for pharmaceutical promotional expenditures: The role of marketing mix interactions. J. Marketing 68(4):90–105.Crossref, Google Scholar
• Nelson J (2003) Cigarette demand, structural change, and advertising bans: International evidence, 1970-1995. Contributions Econom. Anal. Policy 2:10.Google Scholar
• O’Riordan M (2008) Physicians discuss concerns about device DTC advertising with US lawmakers. Commercial Alert, September 19.Google Scholar
• Saffer H (1997) Alcohol advertising and motor vehicle fatalities. Rev. Econom. Statist. 79:431–442.Crossref, Google Scholar
• Saffer H, Chaloupka F (2000) The effect of tobacco advertising bans on tobacco consumption. J. Health Econom. 19:1117–1137.Crossref, Google Scholar
• Sharma M, Yadav K, Yadav N, Ferdinand KC (2017) Zika virus pandemic? Analysis of Facebook as a social media health information platform. Amer. J. Infection Control 45(3):301–302.Crossref, Google Scholar
• Staton T (2009) Fearing FDA. Pharma Abandons Search Ads. FiercePharma, October 7.Google Scholar
• Stewart M (1993) The effect on tobacco consumption of advertising bans in OECD countries. J. Advertising 12:155–180.Crossref, Google Scholar
• Wosinska M (2005) Direct-to-consumer advertising and drug therapy compliance. J. Marketing Res. 42(3):323–332.Crossref, Google Scholar
• Yang S, Ghose A (2010) Analyzing the relationship between organic and sponsored search advertising: Positive, negative, or zero interdependence? Marketing Sci. 29(4):602–623.Link, Google Scholar